Related references
Note: Only part of the references are listed.Endogenous IL-17 contributes to reduced tumor growth and metastasis
Ilona Kryczek et al.
BLOOD (2009)
Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
Mojgan Ahmadzadeh et al.
BLOOD (2009)
Cyclophosphamide Augments Antitumor Immunity: Studies in an Autochthonous Prostate Cancer Model
Satoshi Wada et al.
CANCER RESEARCH (2009)
Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor-specific CD8(+) T cells
Naoko Imai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
Mohamed L. Salem et al.
JOURNAL OF IMMUNOLOGY (2009)
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
Marc Pellegrini et al.
NATURE MEDICINE (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma
Ryo Yamamoto et al.
BLOOD (2008)
Tumor-specific Th17-polarized cells eradicate large established melanoma
Pawel Muranski et al.
BLOOD (2008)
FOXP3+ Tregs and B7-HI+/PD-I+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients:: Implication for immunotherapy
Hazem Ghebeh et al.
BMC CANCER (2008)
Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor β
Shuang Wei et al.
CANCER RESEARCH (2008)
Murine cytomegalovirus induces a polyfunctional CD4 T cell response
Ramon Arens et al.
JOURNAL OF IMMUNOLOGY (2008)
Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1
Naomi N. Hunder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase
Madhav D. Sharma et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeting molecular and cellular inhibitory mechanisms for improvement of antitumor memory responses reactivated by tumor cell vaccine
W. Scott Webster et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8(+) T-cell response to reptide vaccination: Creation of a beneficial host microenvironment involving type IIFNs and myeloid cells
Mohamed L. Salem et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway
Brian T. Fife et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
G Zhou et al.
BLOOD (2006)
Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression
T Hiura et al.
JOURNAL OF IMMUNOLOGY (2005)
The many faces of IL-7: From lymphopoiesis to peripheral T cell maintenance
TJ Fry et al.
JOURNAL OF IMMUNOLOGY (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
IL-7 promotes the transition of CD4 effectors to persistent memory cells
JC Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
SM Kaech et al.
NATURE IMMUNOLOGY (2003)
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
TJ Curiel et al.
NATURE MEDICINE (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Share Paper
